MiniMed outlines impact of Medtronic cyber incident

MiniMed Group, Inc. reported that its parent, Medtronic plc, experienced unauthorized access to certain information technology systems.

Rhea-AI Filing Summary

MiniMed Group, Inc. reported that its parent, Medtronic plc, experienced unauthorized access to certain information technology systems. Medtronic stated it promptly contained the incident, activated incident response protocols, and engaged external cybersecurity experts to investigate and remediate.

Medtronic disclosed it has not identified any impact on its products, patient safety, customer connections, manufacturing and distribution operations, financial reporting systems, or ability to meet patient needs, and does not expect a material impact on its business or financial results. MiniMed is not aware of compromises to its own IT systems and does not currently expect a material impact on its business or financial results.

The filing also outlines potential risks if the situation worsens, including possible data release or misuse, operational and financial impacts, management distraction, litigation, strained third-party relationships, reputational harm, and regulatory scrutiny, and includes standard forward-looking statement cautions.

Insights

Cybersecurity and risk disclosure analyst

Parent cyber incident disclosed; no current material impact but detailed risks outlined.

MiniMed Group, Inc. describes a cybersecurity incident at parent Medtronic involving unauthorized access to certain IT systems. Medtronic reports prompt containment actions, activation of incident response protocols, and engagement of external cybersecurity experts to support investigation and remediation activities.

Both Medtronic and MiniMed state they have not identified impacts on products, patient safety, core operations, or financial reporting systems and do not currently expect a material effect on business or financial results. However, the narrative highlights potential risks such as data release or misuse, operational disruption, litigation, reputational damage, and regulatory scrutiny should circumstances change.

Because the company explicitly frames these effects as potential and emphasizes its current assessment of no material impact, this disclosure is best viewed as a cautious transparency event rather than a confirmed financial setback. Future company filings may update this assessment if the investigation reveals broader consequences.

8-K Event Classification

Item 7.01 — Regulation FD Disclosure

1 item

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Key Terms

Regulation FD Disclosure, unauthorized third party, incident response protocols, forward-looking statements, +2 more

6 terms

Regulation FD Disclosure regulatory

"Item 7.01. Regulation FD Disclosure On April 24, 2026, Medtronic plc"

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

unauthorized third party technical

"Medtronic plc announced that an unauthorized third party had accessed data"

incident response protocols technical

"it promptly took steps to contain the incident, activated its incident response protocols"

forward-looking statements regulatory

"This filing contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

reputational risk financial

"reputational risk related to the cybersecurity incident; and regulatory scrutiny"

Reputational risk is the danger that negative public perception—from scandals, poor products, harmful actions, or bad publicity—will damage a company’s trust and standing with customers, partners, regulators and investors. Like a stain on a brand that scares away buyers or lenders, it can reduce sales, increase costs, invite regulatory scrutiny, and cause a company’s stock price or ability to raise capital to fall, making it a key concern for investors.

regulatory scrutiny regulatory

"reputational risk related to the cybersecurity incident; and regulatory scrutiny of the cybersecurity incident"

Regulatory scrutiny is when government agencies closely review a company's actions, products or filings to ensure they follow laws and safety rules. For investors, heightened scrutiny can mean slowed approvals, fines, operational changes or reputational risk — like a detailed safety inspection that can delay a product launch or reveal costly fixes, and therefore can affect revenue, costs and share price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What cybersecurity incident involving Medtronic affected MiniMed Group (MMED)?

An unauthorized third party accessed data in certain Medtronic IT systems. Medtronic promptly contained the incident, activated incident response protocols, and hired external cybersecurity experts. MiniMed reports no known compromise of its own IT systems related to this incident at this time.

Does MiniMed Group (MMED) expect a material financial impact from Medtronic’s cyber incident?

MiniMed currently does not expect the cybersecurity incident at Medtronic to have a material impact on its business or financial results. Medtronic likewise disclosed it does not expect a material impact on its own business or financial results based on its investigation to date.

What operational areas did Medtronic say were unaffected by the cybersecurity incident?

Medtronic stated it has not identified any impact on its products, patient safety, connections to customers, manufacturing and distribution operations, financial reporting systems, or ability to meet patient needs. These areas are described as operating without identified disruption from the incident so far.

What steps did Medtronic and MiniMed take after discovering the cybersecurity incident?

After identifying unauthorized access, Medtronic promptly acted to contain the incident, activated incident response protocols, and engaged external cybersecurity experts. MiniMed is assessing potential impacts and monitoring Medtronic’s analysis of the scope and details of the cybersecurity incident as part of its own review.

What potential risks does MiniMed Group (MMED) highlight from Medtronic’s cybersecurity incident?

MiniMed lists potential risks including unauthorized release or misuse of data, adverse effects on revenue, operating income and cash flows, diversion of management attention, possible litigation, damage to relationships with customers and other parties, reputational harm, and increased regulatory scrutiny related to the cybersecurity incident.

How does MiniMed (MMED) characterize its forward-looking statements about the cyber incident?

MiniMed labels its comments as forward-looking statements subject to risks and uncertainties. It notes actual results could differ materially depending on the incident’s scope, any data release or misuse, operational and financial effects, litigation outcomes, stakeholder reactions, reputational impacts, and regulatory responses.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 08:00 AM Learn about SEC filing dates

false 0002062583 0002062583 2026-04-24 2026-04-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2026

MiniMed Group, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-43183	33-3985981
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

18000 Devonshire St.

Northridge, CA 91325

(Address of principal executive offices) (Zip Code)

(763) 514-4000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of exchange on which registered
Common Stock, $0.01 par value		MMED		The Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01. Regulation FD Disclosure

On April 24, 2026, Medtronic plc (“Medtronic”), the parent company of MiniMed Group, Inc. (“MiniMed”), announced that an unauthorized third party had accessed data in certain of Medtronic’s information technology (“IT”) systems. In its release, Medtronic disclosed that upon identifying the unauthorized access, it promptly took steps to contain the incident, activated its incident response protocols, and engaged leading external cybersecurity experts to support its investigation and remediation efforts. Medtronic also disclosed that based on its investigation to date, it had not identified any impact to its products, patient safety, connections to customers, manufacturing and distribution operations, financial reporting systems, or ability to meet patient needs and did not expect the incident to have a material impact on its business or financial results.

MiniMed at this time is not aware of any compromises to the IT systems used by its business as a result of this incident and does not currently expect that the incident will have a material impact on its business or financial results.

Forward-Looking Statements Disclaimer

This filing contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including statements regarding MiniMed’s current understanding regarding the extent of Medtronic’s cybersecurity incident and the potential impact on MiniMed’s financial condition and results of operations. Factors that could cause actual results to differ materially from those indicated in the forward-looking statements include, but are not limited to, the results of the analysis of Medtronic and MiniMed of the scope and details of the cybersecurity incident; the unauthorized release of any of Medtronic’s or MiniMed’s data, including third party data held by Medtronic or MiniMed, or the use of any such data for any fraudulent purposes; potential adverse impact of the incident on MiniMed’s results of operations, including revenue, operating income and cash flows from operations, and on its financial condition; diversion of management’s attention from operations of MiniMed to address the cybersecurity incident; potential litigation related to the cybersecurity incident; potential adverse effects on relationships with customers, suppliers, patients and other third parties as a result of the cybersecurity incident; reputational risk related to the cybersecurity incident; and regulatory scrutiny of the cybersecurity incident. Additional risks and uncertainties are described in MiniMed’s filings with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words or expressions, such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "looking ahead," "may," "plan," "possible," "potential," "project," "should," "going to," "will," and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. MiniMed does not undertake to update its forward-looking statements or any of the information contained in this filing, including to reflect future events or circumstances.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MiniMed Group, Inc.
Date: April 27, 2026	By:	/s/ Bryan F. Kelly
	Name:	Bryan F. Kelly
	Title:	Senior Counsel, Securities & Corporate Governance, Assistant Corporate Secretary

EXHIBIT INDEX

Exhibit Number		Description
104		Cover Page Interactive Data File (embedded with the Inline XBRL document).

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 33.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 21.8 KB